Entrada Therapeutics
TRDA
#6262
Rank
$0.65 B
Marketcap
$17.59
Share price
1.79%
Change (1 day)
19.17%
Change (1 year)

Entrada Therapeutics (TRDA) - Total debt

Total debt on the balance sheet as of September 2024 : $61.31 Million USD

According to Entrada Therapeutics's latest financial reports the company's total debt is $61.31 Million USD. A companyโ€™s total debt is the sum of all current and non-current debts.

Entrada Therapeutics - Total debt on balance sheet (from 2021 to 2024)

Total debt by year

Year Total debt Change
2023-12-31$68.23 M163.07%
2022-12-31$25.93 M
2021-12-31N/A